Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022

SELL
$0.8 - $1.5 $11,006 - $20,637
-13,758 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$1.24 - $2.75 $3,104 - $6,886
-2,504 Reduced 15.4%
13,758 $18,000
Q4 2021

Feb 08, 2022

BUY
$2.42 - $3.65 $39,354 - $59,356
16,262 New
16,262 $41,000
Q3 2021

Nov 12, 2021

SELL
$2.82 - $3.7 $52,404 - $68,757
-18,583 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$3.5 - $5.48 $2,527 - $3,956
722 Added 4.04%
18,583 $66,000
Q1 2021

May 14, 2021

BUY
$3.16 - $4.89 $9,653 - $14,938
3,055 Added 20.63%
17,861 $63,000
Q4 2020

Feb 09, 2021

BUY
$2.2 - $4.45 $32,573 - $65,886
14,806 New
14,806 $47,000

Others Institutions Holding FBIO

About Fortress Biotech, Inc.


  • Ticker FBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,735,000
  • Market Cap $194M
  • Description
  • Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...
More about FBIO
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.